Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216359
Status:
UNKNOWN
Last Update Posted:
2005-10-25
First Post:
2005-09-14
Brief Title:
Cohort Study for Patients Using Fuzeon Enfuvirtide
Sponsor:
Institute for Interdisciplinary Infectiology
Organization:
Institute for Interdisciplinary Infectiology
Study Overview
Official Title:
The Radata-Fuzeon Cohort - An Observational Cohort-Study in HIV-Infected Patients Using Fuzeon Enfuvirtide as Part of Their Antiretroviral Combination Therapy
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon Enfuvirtide in daily clinical practice Patients planned to take this drug in a new antiretroviral combination therapy ART are eligible to participate in this observation
Physicians may register patients online via the internet They are offered to get an expert advice suggesting therapeutics for a new ART
Observation interval is every three month However physicians are allowed to initiate new diagnostics expert advice and therapeutic changes independently from these intervals if necessary
Total observation time for each patients is planned for two years
Physicians may register patients online via the internet They are offered to get an expert advice suggesting therapeutics for a new ART
Observation interval is every three month However physicians are allowed to initiate new diagnostics expert advice and therapeutic changes independently from these intervals if necessary
Total observation time for each patients is planned for two years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None